Overview
News
Salaries
Products
People
Growth
Offices
Financials

Overview

Find important information about IMBRUVICA® (ibrutinib) uses, dosing, support, and more on the official patient website. See full Prescribing & Safety Information.

News

News abbvie.com
AbbVie.comPatientAccessSupport
The most common side effects of IMBRUVICA in adults with B-cell malignancies (CLLSLL and WM) include low platelet count; diarrhea; tiredness; muscle, bone, and joint pain; low white blood cell count; rash; low red blood cell count (anemia); bruising; and
Read more
Report